Cite
The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial.
MLA
Kyungil Park, et al. “The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients with Chronic Kidney Disease: A Study Protocol for a Prospective Randomized Controlled Clinical Trial.” Trials, vol. 11, Jan. 2010, pp. 122–26. EBSCOhost, https://doi.org/10.1186/1745-6215-11-122.
APA
Kyungil Park, Woo-Young Chung, Jae-Bin Seo, Sang-Hyun Kim, Joo-Hee Zo, Kim, M.-A., & Young-Bae Park. (2010). The prevention of contrast induced nephropathy by sarpogrelate in patients with chronic kidney disease: a study protocol for a prospective randomized controlled clinical trial. Trials, 11, 122–126. https://doi.org/10.1186/1745-6215-11-122
Chicago
Kyungil Park, Woo-Young Chung, Jae-Bin Seo, Sang-Hyun Kim, Joo-Hee Zo, Myung-A. Kim, and Young-Bae Park. 2010. “The Prevention of Contrast Induced Nephropathy by Sarpogrelate in Patients with Chronic Kidney Disease: A Study Protocol for a Prospective Randomized Controlled Clinical Trial.” Trials 11 (January): 122–26. doi:10.1186/1745-6215-11-122.